Commitment to User Privacy
IQPC is committed to protecting your privacy. You can visit most pages on our site without giving us any information about yourself. But sometimes we do need information to provide services that you request. This document is designed to give a clear explanation of IQPC's data processing practices. Please see below for further information or if you have any questions or concerns relating to IQPC's site and/or data protection, please e-mail firstname.lastname@example.org.
The Information We Collect & the Primary Purpose for its Collection
The information you provide is being collected by IQPC for the purpose of processing your registration or enquiry. The provision of this information is voluntary. However, if you do not provide the information requested, we may be unable to process your registration or enquiry. All information provided by you will be held in the strictest confidence.
The information we collect on our sites includes (however is not limited to):
• Full Name & Job Title
• Company Name & Address
• Phone & Fax Number
• Email Address
• Interest Areas & Preferences
IQPC is the sole owner of the information collected this site.
Membership of IQPC's Divisional Sites
In order to provide our web site users with a personalised and valuable service, we operate several divisions, which require membership. As above, we will collect information from users during the membership process.
When you visit our site, a cookie (a very small text file) is placed on your machine (if it is accepted), this to provide you with a personalised experience and to assist in the collection of the site visitation statistics. You may refuse the cookie, if you wish. To do so, you will need to check your browser settings.
IQPC collects certain information about your computer hardware and software, this includes (however is not limited to):
• Your IP Address
• Browser Type
• Operating System
• Access Times
• Referring Web Site Addresses
This information is used for the operation of the service, to maintain quality of the service, and to provide general statistics regarding use of IQPC's web sites. Cookies are also used in connection with the membership of our site. If you choose to not have your browser accept cookies, you will be able to view the majority of our site, however you will not you be able to register as a site member.
Information Sharing: Who We Intend to Share Information With and Why
We do not share, rent or sell our customer e-mail lists. We may share other contact information with other professional organisations (including our event sponsors/exhibitors) to promote similar products and services. If you do not want to make your details available please email email@example.com indicating either or both of the statements below;
• I do not wish to have my details made available to other organisations
• I do not wish to receive information about IQPC events or services
No list supplied by IQPC may be used by anyone other than for the confidential use of the original mailer. All lists are seeded with decoy names to protect against abuse; violators will be prosecuted.
Links to Other Web Sites
IQPC contains some links to other sites. Please be aware that IQPC is not responsible for the privacy practices of such other sites. This privacy statement applies solely to the information collected by IQPC.
Surveys & Promotions
From time to time IQPC may run surveys and promotions and may request information from users as part of these. Participation in these is entirely voluntary.
IQPC takes precautions to protect your information. When users submit sensitive information (such as a credit card number) over the internet, we protect it through the use of encryption, such as the Secure Socket Layer (SSL) protocol. Access to all of our users' information is restricted in our offices. Only employees who need the information to perform a specific job are granted access to personally identifiable information. The servers that we store personally identifiable information on are kept in a secure environment.
Correcting, Updating or Removing Your Personal Information
If your personal information is incorrect, changes or if you no longer wish to receive information from IQPC, we will endeavour to correct, update or remove your information as swiftly as possible. This can be done by e-mailing firstname.lastname@example.org.
Special Notice for our Australian Customers Please direct any queries you may have in relation to the use of information about you to IQPC's Database Integrity Maintenance Department:
• Telephone: 02 9223 2700
• Fax: 02 9223 2622
• Mail: Level 6, 25 Bligh Street, Sydney, NSW 2000
• Email: email@example.com
If you no longer wish to receive newsletters or promotional materials, you may opt-out of receiving these communications by following the unsubscribe method on the promotional piece or returning the item(s) to us with "unsubscribe" marked upon it. However, very occasionally, it may be necessary to send you important service announcements about a conference you are attending, for example, we may contact you to inform you of a venue change.
Notification of Changes
Taking a New Approach: Pfizer's Graham Martin on the Benefits & Lessons Learnt from Developing a Geographical Zoning ApproachWed, 10/23/2013
Ahead of the 13th Annual Cool Chain & Controlled Room Temperature Logistics Europe in January, Cold Chain IQ caught up with industry keynote speaker Graham Martin, Supply Chain Excellence Senior Manager, Pfizer Havant UK - supporting Pfizer Global Logistics, to find out the benefits and key principles of developing a geographical zoning...
USDA’s Food Safety and Inspection Service Dr. Regina Tan on Managing and Reducing the Risk of Food RecallsSun, 09/29/2013
In this exclusive Cold Chain IQ interview, Dr. Regina L. Tan Director, Recall Management and Technical Analysis Staff , Office of Field Operations, Food Safety and Inspection Service (FSIS), United States Department of Agriculture (USDA), speaks to Andrea Charles from Cold Chain IQ about the key logistical challenges for an effective recall and...
In this interview Robert Knetl, Director of Washington Operations at Georgia Tech Research Institute, speaks to Andrea Charles from Cold Chain IQ, about the challenges of managing silos and protecting proprietary information in the supply chain whilst trying to ensure supply chain integrity. Knetl also shares his insights on the cloud and his...
In this interview Mark Lovell, Senior Cold Chain Specialist from Shire talks to Andrea Charles from Cold Chain IQ, about the increasing focus by the regulators on controlled room temperature (CRT) / ambient products, investment levels in temperature controlled distribution and recent trends. Lovell also imparts his top tips for optimising...
Ocean container freight is considered a less expensive transportation mode for goods, and can be a good option for lower-cost, more stable solid-dose products. In this exclusive interview Terence Dunleavy, Director, Global Transportation Operations, Hospira, speaks to Andrea Charles from Cold Chain IQ, about the migration from air to ocean,...
Meeting the Challenges of Today's Cold Chain LogisticsThe transportation and logistics of bio-pharmaceutical products is a very complex process. In this Cold Chain interview Tom Grubb, Manager, Cold Chain Strategy, American Airlines Cargo, highlights current trends he is witnessing in the logistics and storage of temperature-sensitive life science...
Mary Foster is the chair of the USP's committee on Packaging, Storage and Distribution. In this podcast, she discusses the regulatory challenges of transporting and distributing clinical trial materials and biologics, and also her position with Athena Pharma Solutions. Have Your SayRate this feature and give us your feedback in the comments...
Gary Hutchinson, President of Modality Solutions, spent over decade directing cold chain logistics at Amgen and Edwards Lifesciences. In this podcast, he discusses best practices for transporting biologics and what emerging technologies will impact the supply chain. Have Your SayRate this feature and give us your feedback in the comments section...
Jacques Dysli, Partner at Supply Chain Operations SA, talks to Andrea Charles from Cold Chain IQ, about current tactics for achieving supply chain integrity and data visibility for risk mitigation, the hottest topics in the temperature controlled supply and how the new GDP guidelines are impacting controlled rooom temperature( CRT) logistics and...
The European Commission issued final revised Good Distribution Practices (GDP) guidelines on 8 March 2013. In this exclusive interview Thomas Brýckner, Head of Pharmaceutical Affairs/ Medical Devices/ CAM of The German Pharmaceutical Industry Assosciation (BPI), speaks to Andrea Charles from Cold Chain IQ, about how revised guidelines on good...
In this interview Meserve Platt, Associate Director Materials / Facilities, Crescendo Bioscience, Inc., speaks to Andrea Charles from Cold Chain IQ, about finding the right partners to improve service levels, managing reverse logistics and 3rd party partnerships and collaborations. Platt also shares his future outlook on the diagnostic landscape...
What is the weakest link in cold chain supply? Will cloud computing revolutionise the biopharmaceutical supply chain? In this interview Carlos Castro Global Transportation and Logistics, Bayer Healthcare and Andrea Charles from Cold Chain IQ, discuss the importance of quality biologistics, key regulatory and operation considerations for cold chain...
In this exclusive interview Jay Johnson, DGSA, Regulatory Compliance from Inmark, and Chairman of the Dangerous Goods Advisory Council (DGAC) Board of Directors, speaks to Andrea Charles from Cold Chain IQ, about new initiatives at the DGAC, the key challenges of shipping dangerous biologics and shares his top tip for successful secure and...
Ministry of Health's Taha Yayci on Turkey's Pharmaceutical Tracking System: Cost, Control and Counterfeiting - Part OneWed, 12/19/2012
"It's not impossible". Taha Yayci, M.S. Republic of Turkey Ministry of Health. The Turkish "Pharmaceutical Track and Trace System" (abbreviated as ITS) defines the infrastructure constructed to track and trace all units belonging to each pharmaceutical product in Turkey. ITS is the application of the well-known "Track & Trace" structure...
In 2013 Health Canada begins its 3 year cycle of updating Guidlines for Temperature Control of Drug Products during Storage and Transportation (GUI-0069). Allan Reynolds, Vice President, Industry and Member Relations for theCanadian Association for Pharmacy Distribution Management (CAPDM), speaks to Andrea Charles from Cold Chain IQ, about the...
In recent years we have witnessed an increase in fraudulent pick up as thieves have become more sophiscated. In this Cold Chain IQ interview , Alan F. Spear, Director, Cargo Security Loss Control, US/Canada at AIG & Immediate Past Chair, TAPA Americas and Andrea Charles, Editor for Cold Chain IQ, discuss the latest trends in supply chain...
Johannes Schoen on the EU Falsified Medicines Directive, Weak Links & Top Tips for Improving Supply Chain VisibilityThu, 11/08/2012
In this interview Johannes Schoen, Senior Manager, Anti-Counterfeiting at Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about the key uncertainties surrounding pharmaceutical serialisation and the impact recent serialisation initiatives will have on the pharma industry. Schoen also shares his thoughts on the implications the...
In Part 1 of this podcast interview, Arminda O. Montero, Global Distribution QA Program Manager Abbott, and Andrea Charles Editor Cold Chain IQ, discuss establishing a global qualification master plan, risk management, quality processes and common misconceptions in the temperature controlled pharmaceutical supply chain. Have Your SayRate this...
Central and Eastern Europe is a rapidly emerging market for pharmaceutical distribution with huge growth occurring across the region. In this podcast Jan Slezak, Logistics & Supply Chain Manager at NEOMED, and Andrea Charles from Cold Chain IQ, discuss the biggest challenges with distribution in the Central & Eastern Europe (CEE) region...
Frank Binder, Director of International Logistics and Supply Chain at Celgene, joins Cold Chain IQ to discuss how pharmaceutical distribution can add more value to business. Firstly, he discusses the importance of the ‘last mile’ to the overall supply chain. He then reflects on the change across the industry at the moment when it comes to...
Genzyme's Chris Wallace on Temperature Controlled Distribution to Small Patient Pools and Change Management in the End-to-End Supply ChainTue, 06/26/2012
"A problem shared is a problem minimised." In this podcast Chris Wallace, Distribution Director, Europe at Genzyme, speaks to Andrea Charles, Editor for Cold Chain IQ, live at IQPC's Nordic Pharmaceutical Supply Chain Forum . Wallace shares his insights on trends in the end-to-end supply chain, the challenges of temperature controlled distribution...
Counterfeit and substandard drugs kill over 100,000 people per year and may indirectly cause the death of nearly 1 million patients. In this podcast economist and author Roger Bate and IQ editor Andrea Charles, discuss the cost of counterfeit and substandard medicines to the global economy, where the greatest of counterfeiting threat comes from...
In this interview Humberto Laserna, Quality Coordinator, Pfizer Peru and Cold Chain IQ Advisor, speaks to Andrea Charles from Cold Chain IQ, about the key challenges of defining and implementing a quality strategy for cold chain supply in Latin America, access and distribution for temperature controlled pharmaceuticals in Peru and the amount of...
In this Cold Chain IQ podcast Fadi Badr, Logistic Manager, Mersaco, speaks to Andrea Charles from Cold Chain IQ, about supply chain challenges for raw temperature sensitive materials, preferred means of transportation in the MENA region and technology's impact on the temperature controlled logistics market. Bahr also shares his insights on current...
Bayer Healthcare's Carlos Castro on Global Supply Chain Harmonisation – Collaboration with Your Freight ForwarderTue, 04/24/2012
With increased global pharmaceutical operations, including significant growth in emerging markets, the need for more intense conversations between partners is becoming ever more crucial. As the pharmaceutical industry seeks to outsource non-core activities it creates a great opportunity for innovative solution providers to go beyond basic freight...